Biogen Idec Inc (BIIB)

BIIB (NASDAQ:Drugs)
$357.53
pos +0.00
+0.00%
Today's Range: 352.03 - 359.87 | BIIB Avg Daily Volume: 1,762,400
Last Update: 01/23/15 - 3:59 PM EST
Volume: 0
YTD Performance: 5.33%
Open: $0.00
Previous Close: $353.65
52 Week Range: $272.02 - $366.17
Oustanding Shares: 236,155,407
Market Cap: 83,516,359,686
6-Month Chart
TheStreet Ratings Grade for BIIB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 11 10 11
Moderate Buy 1 1 1 1
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.61 1.65 1.69 1.65
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 33.49
Price Earnings Comparisons:
BIIB Sector Avg. S&P 500
33.49 33.50 26.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
13.12% 13.52% 207.39%
GROWTH 12 Mo 3 Yr CAGR
Revenue 32.60 0.47 0.14
Net Income 34.90 1.07 0.27
EPS 35.80 0.97 0.25
Earnings for BIIB:
EBITDA 1.90B
Revenue 5.81B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $3.74 $3.83 $13.47 $16.67
Number of Analysts 2 1 2 2
High Estimate $3.79 $3.83 $13.51 $16.77
Low Estimate $3.69 $3.83 $13.42 $16.56
Prior Year $2.33 $2.45 $8.93 $13.47
Growth Rate (Year over Year) 60.52% 56.33% 50.78% 23.77%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Use the overall weakness to pick up the America First stocks.

Braving Biotech Real Money Pro($)

Do you need to pick one name?
Bullish
Jan 06, 2015 | 7:49 AM EST
Coverage of BIIB was started with an Overweight rating, Barclays said. $425 price target. Company has a solid pipeline and Tecfidera sh...
Here's how to trade some key price relationships.
Throughout this historic run, four groups have consistently led the market.
There had been no catalysts.
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
A litany of reasons why you should calm your nerves.
An immense market rotation is happening.
In this era of turmoil, investors can take comfort in this sector.

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.